Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1153)
Relay Therapeutics, Inc. (RLAY)
Rahmer Peter — Chief Corporate Development Officer
Shares
753
Price
$14.79
Total Value
$11.14K
Shares Held After
275,857
% of Holdings
0.3%
BRIGHT MINDS BIOSCIENCES INC. (DRUG)
Cormorant Asset Management, LP — Former 10% Owner
Shares
109,331
Price
$89.50
Total Value
$9.79M
Shares Held After
950,000
% of Holdings
10.3%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
1,490
Price
$14.79
Total Value
$22.04K
Shares Held After
418,557
% of Holdings
0.4%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
972
Price
$14.79
Total Value
$14.38K
Shares Held After
212,895
% of Holdings
0.5%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
1,626
Price
$71.79
Total Value
$116.73K
Shares Held After
44,909
% of Holdings
3.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
95,412
Price
$0.73
Total Value
$69.65K
Shares Held After
2,010,508
% of Holdings
4.5%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
25,000
Price
$18.02
Total Value
$450.50K
Shares Held After
1,751,039
% of Holdings
1.4%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
13,099
Price
$50.10
Total Value
$656.26K
Shares Held After
12,546
% of Holdings
51.1%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAAO and PAO
Shares
700
Price
$30.83
Total Value
$21.58K
Shares Held After
181,219
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAAO and PAO
Shares
17,235
Price
$30.33
Total Value
$522.74K
Shares Held After
181,919
% of Holdings
8.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
366
Price
$571.79
Total Value
$209.27K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
228
Price
$571.08
Total Value
$130.21K
Shares Held After
40,879
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
926
Price
$569.88
Total Value
$527.71K
Shares Held After
41,107
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,531
Price
$568.93
Total Value
$871.04K
Shares Held After
42,033
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,123
Price
$568.07
Total Value
$1.77M
Shares Held After
43,564
% of Holdings
6.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,489
Price
$567.01
Total Value
$844.28K
Shares Held After
46,687
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,598
Price
$566.14
Total Value
$904.70K
Shares Held After
48,176
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$565.18
Total Value
$135.08K
Shares Held After
49,774
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
54
Price
$162.14
Total Value
$8.76K
Shares Held After
6,666
% of Holdings
0.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
89
Price
$161.72
Total Value
$14.39K
Shares Held After
6,720
% of Holdings
1.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
120
Price
$160.27
Total Value
$19.23K
Shares Held After
6,809
% of Holdings
1.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
380
Price
$159.42
Total Value
$60.58K
Shares Held After
6,929
% of Holdings
5.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
62
Price
$158.71
Total Value
$9.84K
Shares Held After
7,309
% of Holdings
0.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
222
Price
$157.49
Total Value
$34.96K
Shares Held After
7,371
% of Holdings
2.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
53
Price
$156.61
Total Value
$8.30K
Shares Held After
7,593
% of Holdings
0.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
8
Price
$155.36
Total Value
$1.24K
Shares Held After
7,646
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
12
Price
$154.65
Total Value
$1.86K
Shares Held After
7,654
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.52
Total Value
$45.18K
Shares Held After
3,062,000
% of Holdings
0.3%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
53,940
Price
$0.85
Total Value
$45.85K
Shares Held After
2,105,920
% of Holdings
2.5%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,037
Price
$14.23
Total Value
$270.90K
Shares Held After
377,802
% of Holdings
4.8%
Orchestra BioMed Holdings, Inc. (OBIO)
RTW INVESTMENTS, LP — 10% Owner
Shares
32
Price
$4.13
Total Value
$132.16
Shares Held After
9,556,063
% of Holdings
0.0%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
400
Price
$134.34
Total Value
$53.73K
Shares Held After
54,400
% of Holdings
0.7%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
1,049
Price
$132.88
Total Value
$139.39K
Shares Held After
54,800
% of Holdings
1.9%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
1,671
Price
$131.66
Total Value
$220.01K
Shares Held After
55,849
% of Holdings
2.9%
NewcelX Ltd. (NCEL)
Samuel Olivier — Director
Shares
81,818
Price
$2.75
Total Value
$225.00K
Shares Held After
81,818
% of Holdings
100.0%
NewcelX Ltd. (NCEL)
Revel Michel — Director
Shares
54,545
Price
$2.75
Total Value
$150.00K
Shares Held After
957,530
% of Holdings
5.7%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
688
Price
$41.65
Total Value
$28.66K
Shares Held After
214,738
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAAO and PAO
Shares
14,363
Price
$30.46
Total Value
$437.50K
Shares Held After
199,154
% of Holdings
6.7%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAAO and PAO
Shares
29,623
Price
$29.60
Total Value
$876.84K
Shares Held After
213,517
% of Holdings
12.2%
MapLight Therapeutics, Inc. (MPLT)
GILLIS JONATHAN — CAAO and PAO
Shares
7,914
Price
$28.94
Total Value
$229.03K
Shares Held After
243,140
% of Holdings
3.2%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
1,576
Price
$37.78
Total Value
$59.54K
Shares Held After
175,342
% of Holdings
0.9%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
7,821
Price
$30.50
Total Value
$238.54K
Shares Held After
211,190
% of Holdings
3.6%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
29,255
Price
$29.63
Total Value
$866.83K
Shares Held After
219,011
% of Holdings
11.8%
MapLight Therapeutics, Inc. (MPLT)
Kreitzer Anatol — Chief Discovery Officer
Shares
8,346
Price
$28.96
Total Value
$241.70K
Shares Held After
248,266
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
Raben David — Chief Medical Officer
Shares
5,500
Price
$22.88
Total Value
$125.83K
Shares Held After
55,286
% of Holdings
9.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$572.22
Total Value
$68.67K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,417
Price
$571.49
Total Value
$809.80K
Shares Held After
40,633
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,653
Price
$570.57
Total Value
$943.16K
Shares Held After
42,050
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,891
Price
$569.75
Total Value
$1.08M
Shares Held After
43,703
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
583
Price
$568.58
Total Value
$331.48K
Shares Held After
45,594
% of Holdings
1.3%
Showing 101–150 of 1153 transactions (page 3 of 24)